Romaco Offi cially Opens New Hyderabad Sales & Service Centre
Romaco India hosted a successful Customer Meet in Hyderabad at the beginning of July. The event to mark the offi cial opening of the new Sales & Service Centre there was attended by 400 invited guests from the pharmaceutical industry. The joint branch will enable Romaco and Truking, its Chinese parent company, to strengthen their presence in the crucial Indian growth market and indeed throughout the South Asian region. Following a Lighting Lamp Ceremony, Romaco CEO Jörg Pieper introduced the Romaco India team and outlined the strategy for the future. In a series of presentations, interspersed with traditional dance performances, turnkey solutions developed by Romaco specifi cally for the Indian market were described and demonstrated.
The new Sales & Service Centre Romaco India Pvt Ltd has offi ces in Mumbai and Hyderabad. The two sites will put Romaco in a strong position on the Indian subcontinent, ideally with a beacon effect right across South Asia and into Northern Africa. Amol Nikam, General Manager of Romaco India with responsibility for customer service, can draw on more than 15 years of professional experience handling machinery and equipment for the pharmaceutical industry. He emphasised how important it is for high technology to interact with customer proximity: “Our sales reps and service technicians can be on the spot in less than a day and they speak the local languages. That’s vitally important as a condition of robust, long-term partnerships.”
Romaco India will take care of sales and service for the product lines under all six Romaco brands including customised solutions for processing, tableting and packaging.
“Romaco has been operating in India for many years and now fi nally has a
The Romaco India sales team
dedicated subsidiary there. That will strengthen our presence in the region, particularly as a single-source supplier for pharmaceutical solids,” Mr Pieper concluded.
“Indian pharmaceutical companies have always insisted on premium quality,” Mr Nikam explained. “At the same time, manufacturers are open to innovation and their brand loyalty is extremely high.”
50209pr@reply-direct.com
AU$5 Million Federal Government Grant for University and Industry Collaboration with Recce Pharmaceuticals
Recce Pharmaceuticals Ltd, a company developing a new class of broad spectrum antibiotics, have announced a successful grant application as one of five Industrial Partners in collaboration with 16 University and Public Health Organisations, to establish a National Anti-Microbial Resistant (AMR) Research Hub in Sydney, Australia to combat antimicrobial resistance.
The Australian Research Council (ARC) has awarded almost AU$5 million to the Hub. Recce and other leading industry partner organisations will engage with Australia’s key researchers and wider stakeholders to address the urgent challenge of antimicrobial resistance.
Recce Chairman Dr John Prendergast said: “If the world is to address the increasing threat of antimicrobial resistance, it’s vital that governments, industry and academic researchers work together. The funding for this valuable interdisciplinary collaboration will help maximise the value of our product pipeline and accelerate our efforts to identify and commercialise new antibiotics for patients and clinicians worldwide.”
“Participation aligns with our goals of working to make a contribution to global health and we look forward to working with the Hub committee
as a key industry partner,” he said. The Hub is a collaboration between the following organisations:
Universities: University of New South Wales Sydney (Kirby Institute, Centre for Social Research in Health); University of Queensland; Monash University; University of Technology Sydney; University of Melbourne.
Industrial Partners: SpeeDx Pty Ltd; Cepheid; Recce Pharmaceuticals Ltd; Opal Biosciences Ltd; Boulos and Cooper Pharmaceuticals Pty Ltd.
Public Research Organisations: The Global Antibiotic Research & Development Partnership (GARDP); The Foundation for Innovative New Diagnostics (FIND); The Central and Eastern Sydney Primary Health Network; NPS MedicineWise.
Other collaborating organisations: Murdoch Children’s Research Institute, WHO Collaborating Centre for Sexually Transmitted Infections and Antimicrobial Resistance, Melbourne Sexual Health Clinic, Western Sydney Sexual Health Centre, Sydney Sexual Health Centre, PNG Institute of Medical Research, and Thai Red Cross AIDS Research Centre.
50243pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124
